-
Workplaces with vaccine mandates are seeing vaccination rates of 90% or higher. A complex mix of factors, including job security, is driving most workers to get the shots.
-
OSHA, the small, chronically understaffed federal agency in charge of workplace safety, now faces a big challenge: enforcing a federal vaccine rule covering 80 million workers.
-
With COVID-19 vaccine mandates taking effect around the country, requests for religious exemptions are on the rise. Under federal law, employers have a lot of discretion in granting the requests.
-
Boosters are available for higher-risk people who got the Pfizer vaccine. But what about people who got the one-shot Johnson & Johnson? Some doctors say they need an extra shot even more urgently.
-
President Biden said the U.S. will buy 500 million more vaccine doses. The goal is to vaccinate 70% of the world's population within a year. But more rich nations need to pitch in, he said.
-
Pfizer and BioNTech say that early trial results show their vaccine established a strong antibody response against the coronavirus. FDA review is still needed.
-
A mild flu season last year means fewer folks are immune to strains starting to circulate now. Scientists predict 100,000 to 400,000 extra U.S. hospitalizations with the deadly flu virus this year.
-
The Centers for Disease Control and Prevention has expressed concern about the further spread of the delta variant. Health officials have been concerned about holiday weekends during the pandemic.
-
The FDA announced the Pfizer vaccine is the first in the U.S. that is now fully approved. Here's what that means for vaccine mandates and convincing vaccine-hesitant people to get vaccinated.
-
After vaccination, antibody levels can help predict how much protection a COVID shot offers, scientists are learning. The finding could speed up the development of future vaccines.
-
A source familiar with the discussions says administration health experts could make the recommendation for fully vaccinated adults as soon as this week.
-
Researchers are seeking volunteers in the greater Tampa Bay region to participate in the study to evaluate safety and immune responses. Enrollment will begin in the coming days.